Counterfeit anabolic steroids are banned and seized by Anvisa

Last Friday (3), the National Health Surveillance Agency (Anvisa) determined the prohibition and seizure of counterfeit units of the drugs Deca-Durabolin and Sustanon. The decision was taken after the company Aspen Pharma complained about the sale of false units of drugs on behalf of another manufacturer.

Anvisa reported that the counterfeit units have the company Schering-Plough as a manufacturer, but that company had the drug registrations canceled in 2017. Even if they are within their expiry date, drug units are considered counterfeit if they have the Schering-Plough company name, as warned by the agency.

Men with primary and secondary hypogonadism are treated with the drug Sustanon, which assists in testosterone replacement. On the other hand, the anabolic steroid Deca-Durabolin is effective in regenerating tissues affected by serious and chronic diseases.

To ensure the safety of consumers, Anvisa advises that medicines are purchased only in regularized establishments, always inside the complete package and with an invoice. Aspen Pharma is the regular manufacturer of these two drugs.

If any unit is identified as suspected counterfeit, the population should avoid using it and contact Aspen Pharma to confirm the authenticity of the product. It is recommended that the incident be reported immediately through the Notivisa system, as directed by the agency.